Analytical Data
-
基因名
Cd69
- Application
-
别名
Cd69；CLEC2C；Early activation antigen CD69
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q07108
-
表达区间
62-199aa
-
氨基酸序列
SVGQYNCPGQYTFSMPSDSHVSSCSEDWVGYQRKCYFISTVKRSWTSAQNACSEHGATLAVIDSEKDMNFLKRYAGREEHWVGLKKEPGHPWKWSNGKEFNNWFNVTGSDKCVFLKNTEVSSMECEKNLYWICNKPYK
-
分子量
18.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Recombinant Human MRPL16 Protein，His
Cat：PA2000-9449
Recombinant Human CABP1 Protein，His
Cat：PA2000-915DB
Recombinant Human PTGES3 Protein，His
Cat：PA1000-2525
Protein Description
CD69 is an early activation marker expressed on the surface of various immune cells, including T and natural killer (NK) cells, upon their activation. It plays a crucial role in modulating immune responses, influencing cell proliferation, differentiation, and migration. Research into CD69 has gained momentum due to its involvement in autoimmune diseases, viral infections, and cancer. Its unique expression patterns and functional significance make CD69 a valuable target for therapeutic interventions. Recombinant CD69 protein is generated to study its structural and functional properties, understand its role in immune cell activation, and explore its potential as a biomarker or therapeutic target. The production of recombinant CD69 allows for more controlled experiments, facilitating in-depth analyses of its interactions with other immune modulators and receptors. Additionally, this research contributes to the development of novel immunotherapeutic strategies aimed at harnessing and regulating immune responses, with the potential to improve treatment outcomes for various diseases. Overall, the study of recombinant CD69 protein is essential for elucidating the complexities of the immune system and advancing immunological research.
